Corrigendum: The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding (Oncogene (2012) 31 (1442-1458) DOI: 10.1038/onc.2011.331);The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding

Oncogene

Volumn 31, Issue 11, 2012, Pages 1442-1458

  Lee, K M ^a   Choi, W I ^a   Koh, D I ^a   Kim, Y J ^a   Jeon, B N ^a   Yoon, J H ^a   Lee, C E ^b   Kim, S H ^b   Oh, J ^b   Hur, M W ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

CDKN1A; cell proliferation; competition; Kr pok; MIZ 1; p21

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; GLUTATHIONE TRANSFERASE; KIDNEY CANCER RELATED POZ DOMAIN KRUPPEL ZINC FINGER PROTEIN; ONCOPROTEIN; PROTEIN MYC INTERACTING ZINC FINGER; PROTEIN P53; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ARTICLE; BINDING COMPETITION; BONE MARROW CANCER; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; KIDNEY CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

EID: 84858335072     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2017.115     Document Type: Erratum

References (44)

1. Albagli O, Dhordain P, Deweindt C, Lecocq G, Leprince D. (1995). The BTB/POZ domain: A new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ 6: 1193-1198.
2. Aravind L, Koonin EV. (1999). Fold prediction and evolutionary analysis of the POZ domain: Structural and evolutionary relationship with the potassium channel tetramerization domain. J Mol Biol 285: 1353-1361.
3. Bardwell VJ, Treisman R. (1994). The POZ domain: A conserved protein-protein interaction motif. Genes Dev 8: 1664-1677.
4. Barna M, Hawe N, Niswander L, Pandolfi PP. (2000). Plzf regulates limb and axial skeletal patterning. Nat Genet 25: 166-172.
5. Basu S, Liu Q, Qiu Y, Dong F. (2009). Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1. Proc Natl Acad Sci USA 106: 1433-1438.
6. Chang CC, Ye BH, Chaganti RS, Dalla-Favera R. (1996). BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci USA 93: 6947-6952.
7. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY et al. (1993). Fusion between a novel krûppel-like zinc finger gene and the retinoic acid receptor-A locus due to a vatiant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 12: 1161-1167.
8. Choi WI, Jeon BN, Park H, Yoo JY, Kim YS, Koh DI et al. (2008). Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-Acid synthase gene (FASN). J Biol Chem 283: 29341-29354.
9. Choi WI, Jeon BN, Yun CO, Kim PH, Kim SE, Choi KY et al. (2009). Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1. J Biol Chem 284: 12633-12644.
10. Costoya JA, Hobbs RM, Barna M, Cattoretti G, Manova K, Sukhwani M et al. (2004). Essential role of Plzf in maintenance of spermatogonial stem cells. Nat Genet 36: 653-659.
11. Deltour S, Guerardel C, Leprince D. (1999). Recruitment of SMRT/ N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: The case of HIC-1 and gFBP-B. Proc Natl Acad Sci USA 96: 14831-14836.
12. Dhordain P, Albagli O, Lin R J, Ansieau S, Quief S, Leutz A et al. (1997). Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc Natl Acad Sci USA 94: 10762-10767.
13. Dong S, Zhu J, Reid A, Strutt P, Guidez F, Zhong HJ et al. (1996). Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc fingerretinoic acid receptor-A fusion protein. Proc Natl Acad Sci USA 93: 3624-3629.
14. el-Deiry WS, Harper JW, O0Connor PM, Velculescu VE, Canman CE, Jackman J et al. (1994). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174.
15. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
16. Farkas G, Gausz J, Galloni M, Reuter G, Gyurkovics H, Karch et al. (1994). The Trithorax-like gene encodes the drosophila GAGA factor. Nature 371: 806-808.
17. Gartel AL. (2009). p21 WAF1/CIP1 and cancer: A shifting paradigm? Biofactors 35: 161-164.
18. Gartel AL, Radhakrishnan SK. (2005). Lost in transcription: P21 repression, mechanisms, and consequences. Cancer Res 65: 3980-3985.
19. He X, Park K, Kappes DJ. (2010). The role of ThPOK in control of CD4/CD8 lineage commitment. Annu Rev Immunol 28: 295-320.
20. Huynh KD, Fischle W, Verdin E, Bardwell VJ. (2000). BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev 14: 1810-1823.
21. Issa JP, Zehnbauer BA, Kaufmann SH, Biel MA, Baylin SB. (1997). HIC1 hypermethylation is a late event in hematopoieic neoplasms. Cancer Res 57: 1678-1681.
22. Jeon BN, Choi WI, Yu MY, Yoon AR, Kim MH, Yun CO et al. (2009). ZBTB2, a novel master regulator of the p53 pathway. J Biol Chem 284: 17935-17946.
23. Jeon BN, Yoo JY, Choi WI, Lee C E, Yoon H G, Hur MW. (2008). Proto-oncogene FBI-1 (Pokemon/Zbtb7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem 283: 33199-33210.
24. Kerckaert JP, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C. (1993). LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 5: 66-70.
25. Kim MH, Roh HE, Lee MN, Hur MW. (2007). New fast BiFC plasmid assay system for in vivo protein-protein interactions. Cell Physiol Biochem 20: 703-714.
26. Koh DI, Choi WI, Jeon BN, Lee CE, Yun CO, Hur MW. (2009). A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1gene. J Biol Chem 284: 19856-19866.
27. Koonin EV, Senkevich TG, Chernos VI. (1992). A family of DNA virus genes that consists of fused portions of unrelated cellular genes. Trends Biochem Sci 17: 213-214.
28. Koutsodontis G, Tentes I, Papakosta P, Moustakas A, Kardassis D. (2001). Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase Inhibitor p21WAF1/Cip1 gene by the p53 tumor suppressor protein. J Biol Chem 276: 29116-29125.
29. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM et al. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403.
30. Liu Q, Basu S, Qiu Y, Tang F, Dong F. (2010). A role of Miz-1 in Gfi-1-mediated transcriptional repression of CDKN1A. Oncogene 29: 2843-2852.
31. Lin RJ, Nagy L, Inoue S, Shao W, Miller Jr WH, Evans RM. (1998). Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391: 811-814.
32. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon- Cardo C et al. (2005). Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433: 278-285.
33. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959.
34. Ogryzko VV, Wong P, Howard BH. (1997). WAF1 retards S-phase progression primarily by inhibition of Cyclin-dependent kinases. Mol Cell Biol 17: 4877-4882.
35. Peukert K, Staller P, Schneider A, Carmichael G, Hänel F, Eilers M. (1997). An alternative pathway for gene regulation by Myc. EMBO J 16: 5672-5686.
36. Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R. (2005). BCL6 interacts with the transcription factor Miz-1 to suppress the cyclindependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol 10: 1054-1060.
37. Piluso D, Bilan P, Capone JP. (2002). Host cell factor-1 interacts with and antagonizes transactivation by the cell cycle regulatory factor Miz-1. J Biol Chem 277: 46799-46808.
38. Seoane J, Le H, Massague J. (2002). Myc suppression of the p21Cip1 cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729-734.
39. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S et al. (2006). Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287-300.
40. Toledo F, Wahl GM. (2006). Regulating the p53 pathway: In vitro hypotheses, in vivo veritas. Nat Rev Cancer 6: 909-923.
41. Weber A, Marquardt J, Elzi D, Forster N, Starke S, Glaum A et al. (2008). Zbtb4 represses transcription of p21CIP1 and controls the cellular response to p53 activation. EMBO J 27: 1563-1574.
42. Willenbring H, Sharma AD, Vogel A, Lee AY, Rothfuss A, Wang Z et al. (2008). Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis. Cancer Cell 14: 59-67.
43. Yamochi T, Kaneita Y, Akiyama T, Mori S, Moriyama M. (1999). Adenovirus-mediated high expression of BCL-6 in CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-XL. Oncogene 18: 487-494.
44. Zhan F, Barlogie B, Arzoumanian V, Huang Y, Williams DR, Hollmig K et al. (2007). Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood 109: 1692-1700.